Nuvectis Pharma (NVCT) Stock Price, News, Quotes-Moomoo

Log Out

US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist

10.980
+0.170+1.57%

Close Nov 12 16:00 ET

10.560
-0.420-3.83%

Post 16:43 ET

212.14MMarket Cap-9465P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Nuvectis Pharma Gains 69%, Insider Trades Reap Benefit
Simply Wall StNov 10 08:18 ET
Nuvectis Pharma | 10-Q: Q3 2024 Earnings Report
SECNov 5 08:36 ET · Announcements
Nuvectis Pharma Reports Q3 EPS (24c), Consensus (25c)
TipRanksNov 5 07:15 ET
Nuvectis Pharma 3Q Loss/Shr 24c >NVCT
Dow JonesNov 5 07:01 ET
Express News | Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
ReutersNov 5 07:00 ET
Express News | Nuvectis Pharma Q3 Cash & Investments USD 17.2 Million
ReutersNov 5 07:00 ET

Comments

Put on watch. Presenting Oct 23-25. Low float

$Nuvectis Pharma (NVCT.US)$

$Nuvectis Pharma (NVCT.US)$
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics

$Nuvectis Pharma (NVCT.US)$
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
Nuvectis Pharma (NASDAQ: NVCT) has announced that its drug NXP800 has received Orphan Drug Designation from the FDA for treating ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers. This designation is significant as ovarian cancer typically exceeds the 200,000 patient thr...

Pinchie McPincher

$Nuvectis Pharma (NVCT.US)$what just happened this shot up 50%

sarcasticlychalanged

Feb 6, 2023 14:36

$Nuvectis Pharma (NVCT.US)$

Translated

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data